Mach Maciej, Maciejewski Karol, Ostrowski Tomasz, Maciąg Rafał, Sajdek Michał, Gąsiorowski Oskar, Gałązka Zbigniew
Department of General, Vascular, Endocrine and Transplant Surgery, Medical University of Warsaw, Warsaw, POL.
2nd Department of Clinical Radiology, Medical University of Warsaw, Warsaw, POL.
Cureus. 2024 Jul 27;16(7):e65487. doi: 10.7759/cureus.65487. eCollection 2024 Jul.
Renal arteriovenous anomalies are uncommon. They are characterized by an abnormal vascular connection that usually bypasses the capillary bed. Most are acquired arteriovenous fistulas (AVF) while the rest are congenital or idiopathic arteriovenous malformations (AVM). AVF are usually caused by renal interventions, trauma, or neoplastic processes. They can lead to hypertension, heart failure, hematuria, and renal insufficiency. A 69-year-old woman presented with arrhythmia, tachycardia, mild ankle edema, and increasing fatigue. Right kidney color Doppler ultrasound confirmed the presence of a huge AVM with a blood flow of 9 L/minute and a dilated, 35 mm in diameter, right renal vein. Two months later, an attempt to embolize the AVM failed as the Amplatzer™ Vascular Plug II (Abbott Laboratories, Chicago, Illinois, United States) migrated to the pulmonary circulation and was later removed. Complete embolization was achieved by implanting two Amplatzer Vascular Plug IIs, various embolization coils, histoacryl glue, and lipiodol. Control angiography revealed significant stenosis in the right subclavian artery endovascular access, which was managed with BeGraft (Bentley InnoMed GmbH, Hechingen, Germany) and Zilver (Cook Group Incorporated, Bloomington, Indiana, United States) stents. The patient was discharged on the third postoperative day, all her symptoms resolved, and she reported eventual recovery. Three months later, the patient was operated on due to a 40x58 mm pseudoaneurysm at the right femoral access site. Thus, renal AVMs should be included as a potential alternative diagnosis for various symptoms such as hematuria and hypertension resistant to medication. Endovascular embolization is a less-invasive, safer, and more effective option than open surgery but has a risk of complications. Success requires fully occluding the shunted vessel, preventing embolic material migration, and preserving normal arterial branches. It depends on selecting adequate techniques and embolic materials individually, based on etiology and precise vascular anatomy assessment.
肾动静脉畸形并不常见。其特征是存在异常的血管连接,通常绕过毛细血管床。大多数是后天性动静脉瘘(AVF),其余为先天性或特发性动静脉畸形(AVM)。AVF通常由肾脏介入操作、创伤或肿瘤性病变引起。它们可导致高血压、心力衰竭、血尿和肾功能不全。一名69岁女性出现心律失常、心动过速、轻度踝关节水肿和日益加重的疲劳。右肾彩色多普勒超声证实存在一个巨大的AVM,血流量为9升/分钟,右肾静脉扩张,直径达35毫米。两个月后,尝试栓塞该AVM失败,因为Amplatzer™血管封堵器II(美国伊利诺伊州芝加哥雅培实验室)迁移至肺循环,随后被取出。通过植入两个Amplatzer血管封堵器II、各种栓塞线圈、组织黏合剂和碘油实现了完全栓塞。对照血管造影显示右锁骨下动脉血管内通路存在明显狭窄,采用BeGraft(德国黑兴根本特利创新医疗有限公司)和Zilver(美国印第安纳州布卢明顿库克集团公司)支架进行处理。患者术后第三天出院,所有症状均消失,她报告最终康复。三个月后,患者因右股动脉穿刺部位出现一个40×58毫米的假性动脉瘤而接受手术。因此,肾AVM应被视为血尿和药物难治性高血压等各种症状的潜在替代诊断。血管内栓塞是一种比开放手术侵入性更小、更安全且更有效的选择,但存在并发症风险。成功需要完全闭塞分流血管、防止栓塞材料迁移并保留正常动脉分支。这取决于根据病因和精确的血管解剖评估分别选择合适的技术和栓塞材料。